Ignite Creation Date:
2024-05-06 @ 7:15 AM
Last Modification Date:
2024-10-26 @ 11:46 AM
Study NCT ID:
NCT02500550
Status:
COMPLETED
Last Update Posted:
2021-05-18
First Post:
2015-07-14
Brief Title:
Safety and Efficacy of Two Doses of ATIR101 a T-lymphocyte Enriched Leukocyte Preparation Depleted of Host Alloreactive T-cells in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor
Sponsor:
Kiadis Pharma
Organization:
Kiadis Pharma
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-10-09
Start Date Type:
ACTUAL
Primary Completion Date:
2018-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-12-17
Completion Date Type:
ACTUAL
First Submit Date:
2015-07-14
First Submit QC Date:
July 14 2015
Study First Post Date:
2015-07-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2021-01-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2019-08-19
Disp First Submit QC Date:
August 19 2019
Disp First Post Date:
2019-08-20
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2021-05-17
Last Update Post Date:
2021-05-18
Last Update Post Date Type:
ACTUAL